Furthermore, the inclusion of inpatients on haemodialysis or artificial nutrition suggests that closed-loop insulin delivery is adaptable and effective in patients with co-morbidities complicating diabetes management98, 101. This evidence concerns the gene INS and diabetes mellitus.